Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxelidine vs sufentanil PCIA in elderly after abdominal laparoscopy
ChiCTR2400094566Phase 4Recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oliceridine in Postoperative gastrointestinal dysfunction (POGD), postoperative pain, postoperative delirium (POD) and 1 more (2 arms), sponsored by Sun Yat-sen University. Primary endpoint: Patient's self-reported first exhaust time. Started Oct 2024; status: recruiting.
02
Drugs
oliceridine
03
Conditions
Postoperative gastrointestinal dysfunction (POGD)postoperative painpostoperative delirium (POD)postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on ChiCTR2400094566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400094566.